Skip to main content
. 2020 Jun 30;754:137751. doi: 10.1016/j.cplett.2020.137751

Table 5.

Pharmacokinetics and toxicity properties of the three potential inhibitors.

Ligand Ames_test Carcino_Rat BBB permeant hERG P-gp S. Inhibition Constant (nM) 1A2 2C19 2C9 2D6 3A4
6 Mutagen Positive No Low risk No 3.19 No No No No No
1 Non-mutagen Negative No Ambiguous Yes 22.53 No No No No No
8 Non-mutagen Negative No High risk Yes 27.80 No No No No Yes